Amjad Khan

7.4k citations
72 papers · 1.5k indexed · h-index 22
Topics
Nanoplatforms for cancer theranostics (9 papers)Photodynamic Therapy Research Studies (9 papers)Metabolomics and Mass Spectrometry Studies (5 papers)

In The Last Decade

Amjad Khan

65 papers receiving 1.4k citations

Peers

Amjad Khan
Comparison fields: 5 of 130
  • Molecular Biology 567
  • Pulmonary and Respiratory Medicine 233
  • Cancer Research 208
  • Genetics 182
  • Biomedical Engineering 168
Replace Raynoo Thanan with:
Raynoo Thanan Thailand
Tamer M. Abdelghany Egypt
Donato Di Pierro Italy
Shugo Ueda Japan
Milena Hristova United States
Noriko Iwamoto Japan
Qingfeng Pang China
Jie Su China
Sabine Weiskirchen Germany
Amjad Khan relative to Raynoo Thanan Thailand Raynoo Thanan's profile →
Citations per field
00.5×
Raynoo Thanan · 1×
Citations per year

Countries citing papers authored by Amjad Khan

Since Specialization
Citations

This map shows the geographic impact of Amjad Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amjad Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amjad Khan more than expected).

Fields of papers citing papers by Amjad Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amjad Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amjad Khan. The network helps show where Amjad Khan may publish in the future.

Co-authorship network of co-authors of Amjad Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Amjad Khan. A scholar is included among the top collaborators of Amjad Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amjad Khan. Amjad Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 3
5 1
6 0
7 5
8 8
9 39
10 3
11 1
12 36
13 132
14 132
15 41
16 10
17 4
18 0
19 18
20 20

About Amjad Khan

Amjad Khan is a scholar working on Chemical Health and Safety, Complementary and alternative medicine and Biochemistry, having authored 72 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (9 papers), Photodynamic Therapy Research Studies (9 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). The work is most often cited by research in Cancer Research (208 citations), Complementary and alternative medicine (88 citations) and Biochemistry (59 citations). Amjad Khan has collaborated with scholars based in United Kingdom, United States and Pakistan. Frequent co-authors include Alnawaz Rehemtulla, Brian D. Ross, Arul M. Chinnaiyan, Francesco Di Pierro, Alexander Bertuccioli, Somia Iqtadar, Kuei C. Lee, Saeed Khan, Giuseppe Derosa and Pamela Maffioli. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026